Skip to main content
SpringerLink
Log in

Predictive, Preventive and Personalised Medicine as the Medicine of the Future: Anticipatory Scientific Innovation and Advanced Medical Services

  • Chapter
  • First Online:
Anticipation and Medicine

Abstract

Depending on innovation in medical services and healthcare systems as a whole, two potential scenarios are considered. A pessimistic scenario considers the pandemic of type 2 diabetes mellitus and the dramatic increase of neurological disorders, CVD and cancer diseases, with severe economic consequences to the society. The optimistic scenario considers integrated concepts of early, so-called predictive diagnostics, targeted preventive measures, and treatments tailored to the person as the future of healthcare. Global research and implementation programs in bio-medicine, communication amongst scientific entities, healthcare providers, policy-makers, educators, and patient organisations, together with consolidation of professional groups in the field of personalised medicine, will play a decisive role in driving the situation towards one of the two scenarios. PPPM concepts aim to promote the optimistic scenario in Europe and worldwide. The long-term strategies of the European Association for Predictive, Preventive and Personalised Medicine towards scientific and technological innovation as well as advanced medical services are described.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Nadin, M.: Medicine: The Decisive Test of Anticipation. In: Nadin, M.: (ed.) Anticipation and Medicine, pp. 1–25. Springer, Cham (2016).

References

  1. George, B., Cebioglu, M., Yeghiazaryan, K.: Inadequate diabetic care: global figures cry for preventive measures and personalized treatment. EPMA J. 1, 13–18 (2010)

    Article  Google Scholar 

  2. Golubnitschaja, O.: Time for new guidelines in advanced diabetes care: paradigm change from delayed interventional approach to predictive, preventive & personalized medicine. EPMA J. 1, 3–12 (2010)

    Article  Google Scholar 

  3. Golubnitschaja, O., Swanton, C., Danesi, R., Costigliola, V.: Promoting predictive, preventive and personalised medicine: European event of global importance. EPMA J. 2, 131–136 (2011)

    Article  Google Scholar 

  4. Golubnitschaja, O.: Time for new guidelines in advanced healthcare: the mission of the EPMA journal to promote an integrative view in predictive, preventive and personalized medicine. EPMA J. 3, 5 (2012)

    Google Scholar 

  5. Society for Participatory Medicine. http://participatorymedicine.org/

  6. Golubnitschaja, O., Costigliola, V.: EPMA.: general report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European association for predictive, preventive and personalised medicine. EPMA J. 3, 14 (2012)

    Article  Google Scholar 

  7. Golubnitschaja, O., Watson, I.D., Topic, E., Sandberg, S., Ferrari, M., Costigliola, V.: Position paper of the EPMA and EFLM: a global vision of the consolidated promotion of an integrative medical approach to advance health care. EPMA J. 4, 12 (2013)

    Article  Google Scholar 

  8. Andrews, R.J.: Global medical knowledge, local medical implementation: predictive, preventive, and personalised medicine. In: Andrews, R.J. Too Big Succeed—Profiteering in American Medicine, pp. 124–127. iUniverse, Bloomington (2013)

    Google Scholar 

  9. Costigliola, V. (ed.): Healthcare Overview—New Perspectives. Springer (2012)

    Google Scholar 

  10. Redig, A.J., McAllister, S.S.: Breast cancer as a systemic disease: a view of metastasis. J. Intern. Med. 274, 113–126 (2013)

    Article  Google Scholar 

  11. Cox, T.R., Rumney, R.M.H., Schoof, E.M., Perryman, L., Høye, A.M., Agrawal, A., Bird, D., Latif, N.A., Forrest, H., Evans, H.R., Huggins, I.D., Lang, G., Linding, R., Gartland, A., Erler, J.T.: The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature 522, 106–110 (2015)

    Article  Google Scholar 

  12. Golubnitschaja, O., Sridhar, K.C.: Liver metastatic disease: New concepts and biomarker panels to improve individual outcomes Clin. Exp. Metastasis (2016). doi:10.1007/s10585-016-9816-8

  13. Grech, G., Zhan, X., Yoo, B.C., Bubnov, R., Hagan, S., Danesi, R., Vittadini, G., Desiderio, D.M.: EPMA position paper in cancer: current overview and future perspectives. EPMA J. 6, 9 (2015)

    Article  Google Scholar 

  14. Golubnitschaja, O., Debald, M., Yeghiazaryan, K., Kuhn, W., Pešta, M., Costigliola, V., Grech, G.:  Breast cancer epidemic in the early 21st century: Evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures. Tumor Biol. (2016). doi:10.1007/s13277-016-5168-x

  15. Iso, H.: Promoting predictive, preventive and personalized medicine in treatment of cardiovascular diseases. EPMA J. 2, 1–4 (2011)

    Article  Google Scholar 

  16. Helms, T.M., Duong, G., Zippel-Schultz, B., Tilz, R.R., Kuck, K.-H., Karle, C.A.: Prediction and personalised treatment of atrial fibrillation-stroke prevention: consolidated position paper of CVD professionals. EPMA J. 5, 15 (2014)

    Article  Google Scholar 

  17. Mozaffari, M.S. (ed.): New Strategies to Advance Pre/Diabetes Care: Integrative Approach by PPPM. Springer (2013)

    Google Scholar 

  18. Golubnitschaja, O., Yeghiazaryan, K., Cebioglu, M., Morelli, M., Herrera-Marschitz, M.: Birth asphyxia as the major complication in newborns: moving towards improved individual outcomes by prediction, targeted prevention and tailored medical care. EPMA J. 2, 197–210 (2011)

    Article  Google Scholar 

  19. Borisow, N., Döring, A., Pfueller, C.F., Paul, F., Dörr, J., Hellwig, K.: Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy. EPMA J. 3, 9 (2012)

    Article  Google Scholar 

  20. Mähler, A., Mandel, S., Lorenz, M., Ruegg, U., Wanker, E.E., Boschmann, M., Paul, F.: Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases? EPMA J. 4, 5 (2013)

    Article  Google Scholar 

  21. Mandel, S. (ed.): Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future. Springer (2013)

    Google Scholar 

  22. Özgüç, M. (ed.): Rare Diseases—Integrative PPPM Approach as the Medicine of the Future. Springer (2015)

    Google Scholar 

  23. Roberti di Sarsina, P., Iseppato, I.: Why we need integrative medicine. EPMA J. 2, 5–7 (2011)

    Google Scholar 

  24. Roberti di Sarsina, P., Alivia, M., Guadagni, P.: Traditional, complementary and alternative medical systems and their contribution to personalisation, prediction and prevention in medicine-person-centred medicine. EPMA J. 3, 15 (2012)

    Google Scholar 

  25. Wang, W., Russell, A., Yan, Y.: Global health epidemiology reference group (GHERG): traditional Chinese medicine and new concepts of predictive, preventive and personalized medicine in diagnosis and treatment of suboptimal health. EPMA J. 5, 4 (2014)

    Article  Google Scholar 

  26. Bubnov, R.V.: Evidence-based pain management: is the concept of integrative medicine applicable? EPMA J. 3, 13 (2012)

    Article  Google Scholar 

  27. Cafiero, C., Matarasso, S.: Predictive, preventive, personalised and participatory periodontology: “the 5Ps age” has already started. EPMA J. 4, 16 (2013)

    Article  Google Scholar 

  28. Golubnitschaja, O., Costigliola, V.: Dental health: EPMA recommendations for innovative strategies. EPMA J. 5, A119 (2014)

    Article  Google Scholar 

  29. Kunin, A.A., Moiseeva, N.S.: A novel approach for detection of primary tooth caries based on the light influence foundation. EPMA J. 5, A123 (2014)

    Article  Google Scholar 

  30. Trovato, G.M.: Behavior, nutrition and lifestyle in a comprehensive health and disease paradigm: skills and knowledge for a predictive, preventive and personalized medicine. EPMA J. 3, 8 (2012)

    Article  Google Scholar 

  31. Shapira, N.: Women’s higher health risks in the obesogenic environment: a gender nutrition approach to metabolic dimorphism with predictive, preventive, and personalised medicine. EPMA J. 4, 1 (2013)

    Article  Google Scholar 

  32. Oja, P., Titze, S.: Physical activity recommendations for public health: development and policy context. EPMA J. 2, 253–259 (2011)

    Article  Google Scholar 

  33. Graf, C.: Preventing and treating obesity in pediatrics through physical activity. EPMA J. 2, 261–270 (2011)

    Article  Google Scholar 

  34. Alivia, M., Guadagni, P., Roberti di Sarsina, P.: Towards salutogenesis in the development of personalised and preventive healthcare. EPMA J. 2, 381–384 (2011)

    Google Scholar 

  35. Younesi, E., Hofmann-Apitius, M.: From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine. EPMA J. 4, 23 (2013)

    Article  Google Scholar 

  36. Drucker, E., Krapfenbauer, K.: Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA J. 4, 7 (2013)

    Article  Google Scholar 

  37. Lemke, H.U., Golubnitschaja, O.: Towards personal health care with model-guided medicine: long-term PPPM-related strategies and realisation opportunities within “Horizon 2020”. EPMA J. 5, 8 (2014)

    Article  Google Scholar 

  38. Berliner, L., Lemke, H.U. (eds.): An Information Technology Framework for Predictive, Preventive and Personalised Medicine: A Use-Case with Hepatocellular Carcinoma. Springer (2015)

    Google Scholar 

  39. Zhan, X., Desiderio, D.M.: The use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomas. EPMA J. 1, 439–459 (2010)

    Article  Google Scholar 

  40. Hu, R., Wang, X., Zhan, X.: Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer. EPMA J. 4, 2 (2013)

    Article  Google Scholar 

  41. Grech, G., Grossman, I. (eds.): Preventive and Predictive Genetics: Towards Personalised Medicine. Springer (2015)

    Google Scholar 

  42. Waerner, T., Thurnher, D., Krapfenbauer, K.: The role of laboratory medicine in healthcare: quality requirements of immunoassays, standardisation and data management in prospective medicine. EPMA J. 1, 619–626 (2010)

    Article  Google Scholar 

  43. Gahan, P.B. (ed.) Circulating Nucleic Acids in Early Diagnosis, Prognosis and Treatment Monitoring—An Introduction. Springer (2015)

    Google Scholar 

  44. Deigner, H.-P.: Challenges in biobanking in personalized medicine—a biobank society’s view. EPMA J. 5, A128 (2014)

    Article  Google Scholar 

  45. Mandel, S., Morelli, M., Halperin, I., Korczyn, A.: Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacy. EPMA J. 1, 273–292 (2010)

    Article  Google Scholar 

  46. Colley, K.J., Wolfert, R.L., Cobble, M.E.: Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk. EPMA J. 2, 27–38 (2011)

    Article  Google Scholar 

  47. Yap, T.A., Swanton, C., de Bono, J.S.: Personalization of prostate cancer prevention and therapy: are clinically qualified biomarkers in the horizon? EPMA J. 3, 3 (2012)

    Article  Google Scholar 

  48. Coelho, J.F., Ferreira, P.C., Alves, P., Cordeiro, R., Fonseca, A.C., Góis, J.R., Gil, M.H.: Drug delivery systems: advanced technologies potentially applicable in personalized treatments. EPMA J. 1, 164–209 (2010)

    Article  Google Scholar 

  49. Coelho, J. (ed.): Drug Delivery Systems: Advanced Technologies Potentially Applicable in Personalised Treatment. Springer, Dordrecht (2013)

    Google Scholar 

  50. Spivak, M.Y., Bubnov, R.V., Yemets, I.M., Lazarenko, L.M., Tymoshok, N.O., Ulberg, Z.R.: Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology. EPMA J. 4, 20 (2013)

    Article  Google Scholar 

  51. Ohno, T.: Particle radiotherapy with carbon ion beams. EPMA J. 4, 9 (2013)

    Article  Google Scholar 

  52. Golubnitschaja, O., Lemke, H.U., Kapalla, M., Kent, A.: Design in predictive, preventive and personalised medicine. In: Kuksa, I., Fisher, T. (eds.) Design for Personalisation. Gower Publishing, London (2016) (In press)

    Google Scholar 

  53. Polivka, J., Polivka, J., Karlikova, M., Topolcan, O.: Pre-graduate and post-graduate education in personalized medicine in the Czech Republic: statistics, analysis and recommendations. EPMA J. 5, 22 (2014)

    Article  Google Scholar 

  54. Advances in Predictive, Preventive and Personalised Medicine. http://www.springer.com/series/10051

  55. EPMA Journal. www.epmajournal.com

  56. Ausweger, C., Burgschwaiger, E., Kugler, A., Schmidbauer, R., Steinek, I., Todorov, Y., Thurnher, D., Krapfenbauer, K.: Economic concerns about global healthcare in lung, head and neck cancer: meeting the economic challenge of predictive, preventive and personalized medicine. EPMA J. 1, 627–631 (2010)

    Article  Google Scholar 

  57. Fischer, T., Langanke, M., Marschall, P., Michl, S. (eds.): Individualized Medicine—Ethical, Economical and Historical Perspectives. Springer, Dordrecht (2015)

    Google Scholar 

  58. Nadin, M.: The anticipatory profile. An attempt to describe anticipation as process. Int. J. Gen. Syst. 41(1), 43–75 (2012) (Nadin, M. (ed.), Taylor & Francis, London)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiological Clinic, Bonn University, Sigmund-Freud-Str. 25, 53105, Bonn, Germany

    Olga Golubnitschaja

  2. European Association for Predictive, Preventive and Personalised Medicine, Brussels, Belgium

    Vincenzo Costigliola

Authors
  1. Olga Golubnitschaja
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vincenzo Costigliola
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Olga Golubnitschaja .

Editor information

Editors and Affiliations

  1. antÉ—Institute for Research in Anticipatory Systems, University of Texas at Dallas, Richardson, Texas, USA

    Mihai Nadin

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Golubnitschaja, O., Costigliola, V. (2017). Predictive, Preventive and Personalised Medicine as the Medicine of the Future: Anticipatory Scientific Innovation and Advanced Medical Services. In: Nadin, M. (eds) Anticipation and Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-45142-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-45142-8_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-45140-4

  • Online ISBN: 978-3-319-45142-8

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics

Search

Navigation